Tracy M. Valorie
New York, New York
Tracy Valorie is Sr. Director, Worldwide Commercial Lead Ophthalmology, and Glaucoma Asset Lead at Pfizer Inc. She began her pharmaceutical career with Pfizer in 1990 and spent nearly 10 years in Pfizer’s Global Research Division in Groton, CT
In 2000, she transferred to Pfizer’s World Headquarters in New York as a member of the US Commercial Organization, where her primary responsibility was to engage institutions with expertise in pediatric medicine. Here she collaborated on strategic initiatives with foundation representatives, residency program directors, and department chairmen.
In 2002 Ms. Valorie transitioned to Pfizer’s World Wide Commercial Organization on the Anti-Infectives team and later assumed responsibility for the Xalabrands Franchise as the Director of Worldwide Xalabrands (Xalatan and Xalacom). In 2009 she assumed full leadership of Pfizer’s glaucoma franchise with responsibilities spanning early development through late stage commercialization of key products. She also leads a cross-functional team which guides research and development efforts in glaucoma. In 2010 she assumed full leadership of the WW Commercial Organization in addition to her current responsibilities which encompass the areas of glaucoma, retinal disease, and ocular surface disorders.
Ms. Valorie holds a Masters in Business Administration from Rensselaer Polytechnic Institute and a BS in Molecular Biology from the University of Connecticut.